Ambeed.cn

首页 / 抑制剂/激动剂 / / 肾上腺素能受体 / Ivabradine HCl/盐酸伊伐布雷定

Ivabradine HCl/盐酸伊伐布雷定 {[allProObj[0].p_purity_real_show]}

货号:A103870 同义名: Ivabradine (hydrochloride); S 16257

vabradine HCl 是一种 HCN (超极化激活的环核苷酸门控) 通道阻滞剂,能够抑制心脏起搏器电流 (If)。Ivabradine HCl 具有抗惊厥、抗缺血和抗心绞痛活性,可用于心率控制相关的研究和治疗。

Ivabradine HCl/盐酸伊伐布雷定 化学结构 CAS号:148849-67-6
Ivabradine HCl/盐酸伊伐布雷定 化学结构
CAS号:148849-67-6
Ivabradine HCl/盐酸伊伐布雷定 3D分子结构
CAS号:148849-67-6
Ivabradine HCl/盐酸伊伐布雷定 化学结构 CAS号:148849-67-6
Ivabradine HCl/盐酸伊伐布雷定 3D分子结构 CAS号:148849-67-6
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}

{[ getRatePriceInt(item.pr_rmb, 1,1) ]}

{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]}
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} 现货 1周 咨询 - +
购物车0 收藏 询单

Ivabradine HCl/盐酸伊伐布雷定 纯度/质量文件 产品仅供科研

货号:A103870 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Nature, 2025, 645, 793-800. Ambeed. [ A201204 , A444152 , A344107 , A952055 ]
Cell, 2025. Ambeed. [ A122167 ]
Science, 2025, 387(6729): eadp5637. Ambeed. [ A875019 ]
Sig. Transduct. Target. Ther., 2025, 10, 257. Ambeed. [ A104916 ]
Nat. Nanotechnol., 2025. Ambeed. [ A243018 , A1216705 , A522597 , A125401 , A1355641 ]
更多 >
产品名称 Adrenergic Receptor α-adrenergic receptor β-adrenergic receptor 其他靶点 纯度
Ivabradine HCl 98%
Maprotiline HCl 98%
Cisatracurium besylate 96%
Yohimbine HCI 99+%
BMY 7378 ++

α2C-adrenoceptor, pKi: 6.54

α1D-adrenoceptor, pKi: 5.1

+

β1-adrenoceptor, pIC50: 5.1

97%
Asenapine maleate ++++

α2B-adrenergic receptor, pKi: 8.9

α2A-adrenergic receptor, pKi: 8.9

97%
Piribedil ++

adrenoceptor α2C, pKi: 7.2

adrenoceptor α2A, pKi: 7.1

98%
Prazosin HCl 95%
Silodosin 98%
Phenoxybenzamine HCl 98%
Labetalol HCl 98+%
Naftopidil +++

α1A-adrenergic receptor, Ki: 3.7 nM

α1D-adrenergic receptor, Ki: 20 nM

98%
Naftopidil 2HCl +

α1-adrenergic receptor, IC50: 0.2 μM

99%
Alfuzosin HCl 98%
Terazosin HCl 99%
Atipamezole 95%
Phentolamine methanesulfonate salt 99%
Carvedilol 99%
Doxazosin mesylate 99%
Tolazoline HCl 98%
Esmolol HCl 95%
Propranolol HCl ++

β-adrenergic receptor, IC50: 12 nM

99%
Zenidolol HCl ++++

β1-adrenergic receptor, Ki: 611nM

β2-adrenergic receptor, Ki: 0.7nM

98%
Acebutolol HCl 97+%
Carteolol HCl 98+%
Betaxolol 99%
Betaxolol HCl +

β1-adrenergic receptor, IC50: 6 μM

97%
Bisoprolol 97%
Sotalol HCl 95+%
Nebivolol HCl +++

β1-adrenoceptor, IC50: 0.8 nM

99%
Metoprolol 98+%
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。

Ivabradine HCl/盐酸伊伐布雷定 生物活性

靶点
  • Adrenergic Receptor

描述 Ivabradine Hydrochloride is a novel selective inhibitor of hyperpolarization-activated cyclic nucleotide-gated channels, inducing heart rate (HR) reduction[3]. Ivabradine at 10 mg/kg/day reduced the maximal HR increase in response to the β-agonist isoproterenol, without modifying the response of contractile parameters [4]. Ivabradine induced a time-dependent inhibition of hHCN4 with an IC50 of 0.5 μM. Ivabradine 3 μM decreased the frequency of action potentials in SAN (sino-atrial nodes) from guinea-pig, rabbit and pig by 33%, 21% and 15% at 40 min, respectively[5].

Ivabradine HCl/盐酸伊伐布雷定 细胞实验

Cell Line
Concentration Treated Time Description References
MCF-10A 5 µM 2 weeks Clin Transl Med. 2021 Nov;11(11):e578.
MDA-MB-453 5 µM 2 weeks Suppressed cell proliferation Clin Transl Med. 2021 Nov;11(11):e578.
MDA-MB-231 5 µM 2 weeks Suppressed cell proliferation Clin Transl Med. 2021 Nov;11(11):e578.
SAN myocytes 1 µM To evaluate the effect of Ivabradine on the spontaneous beating rate of SAN cells, results showed Ivabradine reduced the beating rate in control cells but had no effect on mutant cells. Nat Commun. 2014 Aug 21;5:4664.
HEK293 cells 30 μM Assess the current properties of HCN4 channels under AP clamp Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2104668118.
Murine sinoatrial node myocytes 30 μM 120 seconds Evaluate the blocking effect of ivabradine on If current Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):e2104668118.
SAN pacemaker cells 3 or 10 µM To evaluate the inhibitory effect of Ivabradine on If current in SAN cells, showing similar inhibition in both control and mutant groups. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12189-94.

Ivabradine HCl/盐酸伊伐布雷定 动物实验

Species
Animal Model
Administration Dosage Frequency Description References
Mice Type 1 and Type 2 diabetes models Intraperitoneal injection 2.5 mg/kg, 5 mg/kg, 10 mg/kg Single or multiple injections Ivabradine significantly reversed mechanical hypersensitivity in diabetic mice in a dose-dependent manner. Multiple injections completely restored pain thresholds to pre-diabetic levels. Sci Transl Med. 2017 Sep 27;9(409):eaam6072
Mice Diabetic mouse model Oral 20 mg/kg/day Once daily for 4 weeks To investigate the effect of selective heart rate reduction on cardiovascular function and ventricular-arterial coupling in a diabetic mouse model. Results showed that Ivabradine improved vascular stiffness and left ventricular systolic and diastolic function. Eur Heart J. 2013 Sep;34(36):2839-49
Mice Swim training model Oral 7.5 mg Single dose To assess the effect of Ivabradine on heart rate Circ Res. 2017 Oct 13;121(9):1058-1068
Mice Ncx1−/− mice 30 µM To investigate the effect of Ivabradine on the automaticity of SAN cells in Ncx1?/? mice, results showed that under basal conditions, Ivabradine similarly reduced SAN cell automaticity in both Ncx1?/? and control mice; however, after isoproterenol stimulation, SAN cells from Ncx1?/? mice were significantly more sensitive to Ivabradine Circ Res. 2013 Jan 18;112(2):309-17
Mice HHCN4-AYA transgenic mice Intraperitoneal injection 6 mg/kg Single dose To evaluate the effect of Ivabradine on heart rate, results showed Ivabradine reduced heart rate in control mice but had no effect on mutant mice. Nat Commun. 2014 Aug 21;5:4664.
Mice Cardiac-specific TRPM7 knockout mice 3 mg/kg and 6 mg/kg KOαMHC-Cre mice were less sensitive to the negative chronotropic effects of ivabradine compared to wild-type mice Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):E3037-46
Mice Atrial-specific NCX knockout mice Perfusion 3 μM Suppressed NCX KO SAN automaticity, reducing burst firing activity Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):9769-74
Nude mice MDA-MB-231 xenograft model Subcutaneous injection 15 mg/kg Once daily for 4 weeks Significantly reduced tumor volume Clin Transl Med. 2021 Nov;11(11):e578.
Mice Conditional hHCN4–573X transgenic mice Intraperitoneal injection 3 or 6 mg/kg Single dose, observed for 3 hours To assess the effect of Ivabradine on heart rate, showing significant reduction in controls but no effect in mutants. Proc Natl Acad Sci U S A. 2009 Jul 21;106(29):12189-94.
Mice Oxaliplatin-induced cold hypersensitivity model Intraperitoneal injection 3 mg/kg Single injection To evaluate the effect of ivabradine on oxaliplatin-induced cold hypersensitivity, it was found that ivabradine significantly alleviated cold hypersensitivity EMBO Mol Med. 2011 May;3(5):266-78

Ivabradine HCl/盐酸伊伐布雷定 参考文献

[1]Lodhi M, Dubey A, et al. Formulation and evaluation of buccal film of Ivabradine hydrochloride for the treatment of stable angina pectoris. Int J Pharm Investig. 2013 Jan;3(1):47-53.

[2]Thollon C, Cambarrat C, et al. Electrophysiological effects of S 16257, a novel sino-atrial node modulator, on rabbit and guinea-pig cardiac preparations: comparison with UL-FS 49. Br J Pharmacol. 1994 May;112(1):37-42.

[3]Simko F, Baka T, Poglitsch M, Repova K, Aziriova S, Krajcirovicova K, Zorad S, Adamcova M, Paulis L. Effect of Ivabradine on a Hypertensive Heart and the Renin-Angiotensin-Aldosterone System in L-NAME-Induced Hypertension. Int J Mol Sci. 2018 Oct 3;19(10):3017.

[4]Du XJ, Feng X, Gao XM, Tan TP, Kiriazis H, Dart AM. I(f) channel inhibitor ivabradine lowers heart rate in mice with enhanced sympathoadrenergic activities. Br J Pharmacol. 2004 May;142(1):107-12.

[5]Thollon C, Bedut S, Villeneuve N, Cogé F, Piffard L, Guillaumin JP, Brunel-Jacquemin C, Chomarat P, Boutin JA, Peglion JL, Vilaine JP. Use-dependent inhibition of hHCN4 by ivabradine and relationship with reduction in pacemaker activity. Br J Pharmacol. 2007 Jan;150(1):37-46.

Ivabradine HCl/盐酸伊伐布雷定 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.98mL

0.40mL

0.20mL

9.90mL

1.98mL

0.99mL

19.80mL

3.96mL

1.98mL

Ivabradine HCl/盐酸伊伐布雷定 技术信息

CAS号148849-67-6
分子式C27H37ClN2O5
分子量 505.05
SMILES Code Cl[H].COC1=CC2=C(CC(=O)N(CCCN(C)C[C@H]3CC4=CC(OC)=C(OC)C=C34)CC2)C=C1OC
MDL No. MFCD00929899
别名 Ivabradine (hydrochloride); S 16257; Ivabradine hydrochloride
运输蓝冰
InChI Key HLUKNZUABFFNQS-ZMBIFBSDSA-N
Pubchem ID 3045381
存储条件

In solvent -20°C: 3-6个月 -80°C: 12个月

Pure form Inert atmosphere, room temperature

溶解方案

DMSO: 25 mg/mL(49.5 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

H2O: 50 mg/mL(99 mM),配合低频超声助溶

请根据您的动物给药指南选择适当的溶解方案。
以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂:
——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
方案 二
配制的工作液建议现用现配,短期内尽快用完。 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
方案 一
AmBeed 相关网站 AmBeed.cn AmBeed.com
AmBeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    AmBeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。